WICH 2019 - Scientific Program

Scientific Program

Time:
​HALL A
15:00-15:05
​Opening
15:05-17:05
SCIENTIFIC SESSION 1
EPIDEMIOLOGY & GENETICS
Moderators:  Rustam Al-Shahi Salman, UK and Daniel Woo, USA
​15:05-15:20
​The changing epidemiological pattern of ICH in the XXI century    
Adnan Qureshi, University of Missouri, USA
15:20-15:27
O-001 Nationwide Prevalence for Opioid Abuse among Hemorrhagic Stroke Patients in the United States
Farhaan Shaheer Vahidy, McGovern Medical School at UTHealth Houston, USA
​15:27-15:34
​O-002 Global Burden of Intracerebral Hemorrhage
Alexander Yacob, Tulane University School of Medicine, USA; Ochsner Clinic Foundation, USA
​15:34-15:49
​Genetic, racial and enviromental risk factors for intracerebral hemorrhage 
Daniel Woo, University of Cincinnati, USA
​15:49-15:56
O-003 Global Burden of Subarachnoid Hemorrhage
Christopher Carr, Tulane University School of Medicine, USA; Ochsner Clinic Foundation, USA
​15:56-16:03
O-004 Primary Intra Cranial Hemorrhage: Impact of Weekend Admissions on the Mortality
Ali Seifi, University of Texas Health at San Antonio, USA
16:03-16:18
Sex-differences in ICH  
Hanne Krarup Christensen, University of Copenhagen, Denmark
​16:18-16:25
O-005 Risk of Intracerebral Hemorrhage in Pregnancy and the Postpartum Period: A Population Based Analysis using a Cohort-Crossover Design
Jennifer R Meeks, McGovern Medical School at UTHealth, USA
​16:25-16:32
O-006 Gender and age differences and its relation to outcome in a large multicenter cohort of patients with intracranial hemorrhage
Daniel Vázquez Justes, Hospital Arnau de Vilanova, Spain
​16:32-16:47
​The underlying cerebral small vessel diseases
Rustam Al-Shahi Salman, University of Edinburgh, United Kingdom
​16:47-16:54
O-007 Estimates and Temporal Trend for Nationwide 30-day Hospital Readmission Among Patients with Hemorrhagic Stroke: A Contemporary Population Based Analysis of 6-Year Nationwide Data
Farhaan Shaheer Vahidy, University of Texas Health Science Center, USA
​16:54-17:01
O-008 Readmissions in the Patients with Intracranial Hemorrhage in the United States
Ali Seifi, University of Texas Health at San Antonio, USA
​17:05-17:30
​COFFEE BREAK
​17:30-19:30
SCIENTIFIC SESSION 2
PATHOPHYSIOLOGY & BASIC SCIENCES
Moderators:  Richard Frederick Keep, USA and Daniel Hanley, USA
​17:30-17:45
​Protecting brain from ICH:  Nrf2 and other cell factors
Jaroslaw Aronowski, The University of Texas Health Science Center, USA
17:45-17:52
​O-010 Investigating the role of SAMHD1 and hypocholesterolaemia in intracerebral haemorrhage
Sarah Withers,  The University of Manchester, United Kingdom
17:52-17:59
O-011 Hemin has a Different Toxicity Pattern than Iron: Why Chelation Alone May Not be Sufficient to Treat Intracerebral Hemorrhage
Thomas A Kent,  Houston Methodist Hospital, USA; Rice University, USA
​17:59-18:14
​Coagulopathy in Traumatic Brain Injury
Marc Maegele, Cologne-Merheim Medical Center - University Witten-Herdecke, Germany
​18:14-18:21
O-090 Feasibility of Improving Cerebral Autoregulation in Acute Intracerebral Haemorrhage (BREATHE-ICH) Study: Results from an Experimental Interventional Study
Jatinder S Minhas, University of Leicester, United Kingdom
​18:21-18:28
O-013 Using zebrafish larval models of brain haemorrhage to measure brain injury, locomotor and neuroinflammatory outcomes in a drug screen
Siobhan Crilly, The University of Manchester, United Kingdom
​18:28-18:43
​New experimental animal models in ICH and SAH
Richard Frederick Keep, University of Michigan, USA
​18:43-18:50
O-014 Assessment of early brainstem injury progression in a collagenase-induced rat brainstem hemorrhage model using multi-sequence magnetic resonance imaging combined with histopathology
Xi Guo,  West China Hospital, China; Sichuan University, China
​18:50-18:57
O-015 Specific Gene Expression Networks Define the Peripheral Immune Response following Intracerebral Hemorrhage in Human
Boryana Stamova, University of California, USA
​18:57-19:12
​Potential targets for SAH / vasospasm
John Zhang, Loma Linda University School of Medicine, USA
​19:12-19:19
O-016 Investigating the role of neuroinflammation and cholesterol metabolism in the progression of brain injury following ICH
Paul Kasher, The University of Manchester, United Kingdom

Time:

​HALL A

08:00-10:00​
SCIENTIFIC  SESSION 3
DIAGNOSING & IMAGING
Moderators:  Magdy Selim, USA and Najia Al Abbadi, Morocco 
​08:00-08:15
​Diagnosing ICH using biomarkers
Joan Montaner Villalonga, Vall D'Hebron Neovascular Research Laboratory, Spain
08:15-08:22
O-017 New and Expanding Ventricular Hemorrhage Predicts Poor Outcome in Acute Intracerebral Hemorrhage
Vignan Yogendrakumar, University of Ottawa, Canada
​08:22-08:29
O-018 Incorporating Intraventricular Hemorrhage Assessment to the Current Definitions of Hematoma Expansion Improves Clinical Outcome Prediction
Vignan Yogendrakumar, University of Ottawa, Canada
​08:29-08:44
​Diagnosing the cause of ICH using imaging
David Werring, UCL Institute of Neurology , United Kingdom
08:44-08:51

​08:51-08:58
O-020 Influence of intracranial artery tortuosity on risk of aneurysm development and rupture
Kornelia M Kliś, Jagiellonian University Medical College, Poland
​08:58-09:13
​Predicting intracerebral hemorrhage expansion
Dariush Dowlatshahi, University of Ottawa, Canada
09:13-09:20
O-021 Clinical Predictors of Withdrawal of Life-Sustaining Treatment for Critically Ill Patients with Intracerebral Hemorrhage and Intraventricular Hemorrhage
Lourdes Carhuapoma,  Johns Hopkins Hospital, USA
​09:20-09:27
O-022 Predicting Intracerebral Hemorrhage Expansion with CT perfusion
Andrea Morotti,  IRCCS Mondino Foundation, Italy
​09:27-09:42
Cognition after ICH
Charlotte Cordonnier, The Lille University Hospital, France
​09:42-09:49
O-023 Low Perihematomal Edema Volumes Associated with Improved Functional Outcome and Lower Mortality in the MISTIE III Trial
W. Andrew Mould, Johns Hopkins Hospital, USA
​09:49-09:56
O-024 Clinical and pathophysiological properties of peak edema extension distance in intracerebral hemorrhage
Bastian Volbers, University of Erlangen-Nuremberg, Germany
10:00-10:30
​COFFEE BREAK
​10:30-12:30
SCIENTIFIC  SESSION 4
TREATMENT & MEDICAL MANAGEMENT
Moderators:  Craig Anderson, Australia and Charlotte Cordonnier, France​
​10:30-10:45
Reversal of oral anticoagulants in SAH, SDH and IVH
Hanno Riess, Charité - Universitätsmedizin Berlin, Germany
​10:45-10:52

​10:52-10:59
O-026 Histotripsy clot liquefaction in a porcine intracerebral hemorrhage model
Aditya S Pandey, University of Michigan, USA
​10:59-11:14
​Measurements of inflammation in ICH in humans
Adrian Parry-Jones, The University of Manchester, United Kingdom
​11:14-11:21
O-027 Blood pressure variability within first 24 hours after admission predicts poor in-hospital outcome in spontaneous intracerebral hemorrhage
Wendy Ziai,  Johns Hopkins University School of Medicine, USA
​11:21-11:28
​11:28-11:43
Anti-inflammatory treatments after ICH
Magdy Selim, Harvard University, USA
11:43-11:50

​11:50-11:57
O-030 GCN2 reduces inflammation by p-eIF2α/ATF4 pathway after intracerebral hemorrhage in mice
Zhengyang Lu, The First Affiliated Hospital of Soochow University, China
​11:57-12:12
Management of blood pressure after ICH
Craig Anderson, The University of Sydney and the Institute of Neurosciences of Royal Prince Alfred Hospital, Australia
​12:12-12:27
Innovations for the management of spontaneous ICH
Dariush Dowlatshahi, Canada
​12:27-12:35
O-031 Intracranial pressure and cerebral perfusion pressure trajectories: A novel approach to informing outcomes in spontaneous intracerebral hemorrhage with large intraventricular extension
Wendy Ziai, Johns Hopkins University School of Medicine, USA
​12:35-13:30
The Hoff Awards
Presented by Richard Frederick Keep, USA​
13:30-15:00
​Networking Event - Lunch Reception
13:45-14:45
Industry Sponsored Luncheon Symposium​
15:00-17:00
​SCIENTIFIC  SESSION 5
ORAL ANTICOAGULANTS AND REVERSAL AGENTS
Moderators: Joan Martí Fabregas, Spain and Thorsten Steiner, Germany
​15:00-15:15
Anticoagulant resumption vs. LAAO in patients with anticoagulation-related ICH
Eivind Berge, Oslo University Hospital, Norway- University of Tromsø, Norway
​15:15-15:22
O-032 A multicenter registration study for nontraumatic intracerebral hemorrhage in the DOAC era
Joji Tokugawa, Junntendo University Nerima Hospital, Japan
​15:22-15:29
O-033 Hemocoagulase atrox is not associated with Hematoma expansion prevention in intracerebral hemorrhage patients: a retrospective study
Yunke Li, West China Hospital of Sichuan University, China
​15:29-15:44
Antithrombotic drugs and the risk of ICH
David Gaist, Odense University Hospital - University of Southern Denmark, Denmark
​15:44-15:51
O-034 Prognosis for intracerebral hemorrhage during ongoing anticoagulant treatment A Swedish stroke register study
Trine Apostolaki Hansson, Lund University, Sweden
​15:51-15:58
O-035 Simulating an Adaptive, Randomized, Clinical Trial of Dose-Response from Time to Anticoagulant Reinitiation (Restart) after Intracranial Hemorrhage
Truman J Milling Jr, University of Texas at Austin, USA
​15:58-16:13
Reversal of new oral anticoagulants
Thorsten Steiner, University of Heidelberg, Germany
​16:13-16:20
O-036 rFVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Thorsten Steiner, Germany
​16:20-16:27
O-037 Comparing Pharmacological Venous Thromboembolism Prophylaxis to Intermittent Pneumatic Compression in Acute Intracerebral Hemorrhage: Systematic Review and Network Meta-Analysis
Vignan Yogendrakumar, University of Ottawa, Canada
​16:27-16:42
Safety and usefulness of haemostatic drugs for acute ICH
Nikola Sprigg, University of Nottingham, United Kingdom
​16:42-16:49
O-038 Direct Assessment of Health Utilities among Patients with Intracerebral Hemorrhage using the Standard Gamble Method
Farhaan Shaheer Vahidy, UTHealth Houston, USA
​16:49-16:56
O-039 Longitudinal prevalence of Cognitive Impairment after Intracerebral Haemorrhage using data from the Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
Andrew Belcher, University of Nottingham, United Kingdom
17:00-17:30
COFFEE BREAK 
17:30-19:30
​SCIENTIFIC  SESSION 6 
FUNCTIONAL RECOVERY & PROGNOSIS
Moderators: Joseph Broderick, USA and Ángel Horcajadas, Spain
​17:30-17:45
Predictors of intracerebral hemorrhage in ischemic stroke treated with fibrinolysis  
Joan Martí Fabregas, Hospital de la Santa Creu i Sant Pau, Hospital de la Santa Creu i Sant Pau, Spain
​17:45-17:52

​17:52-17:59
O-042 Epileptic seizures as a complication in cerebral hemorrhage surgically treated in ICU patients
Maria Del Carmen Molina De La Torre, Hospital Universitario de Jaén, Spain
​17:59-18:14
​Prognosis for serious vascular events after ICH
Karin Klijn, Radboud University Medical Center, The Netherlands
​18:14-18:21
O-043 A Delayed Modified-ICH Score Outperforms Baseline Scoring in Acute Intracerebral Hemorrhage
Ronda Lun,  University of Ottawa, Canada
​18:21-18:28
O-044 Stroke nurse plays a key role in the fast, intensive and sustained blood pressure reduction in acute intracerebral hemorrhage
Olalla Pancorbo, Vall d'Hebron University Hospital, Spain; Vall d'Hebron Research Institute, Spain
​18:28-18:43
​Rehabilitation after hemorrhagic stroke: stroke-subtype specific recovery therapies
Katharina Stibrant Sunnerhagen, University of Gothenburg, Sweden    
​18:43-18:50
​O-045 Nationwide Trends and Disparities in Utilization of In-Patient Rehabilitation for Patients with Hemorrhagic Stroke
Farhaan Shaheer Vahidy,  University of Texas Health Science Center, USA
​18:50-18:57
O-046 Spontaneous Intracerebral Hemorrhage in a Plateau Area: A Study Based on the Tibetan Population
Lu Ma, West China Hospital, Sichuan University, China
​18:57-19:12

Minimally invasive surgery with thrombolysis for intracerebral hemorrhage in China
Zhou-ping Tang, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China

​19:12-19:19
​O-047 Validation of ICH and ICH-GS scores in an Indian cohort
Nishita Singh, All India Institute of Medical Sciences, India
​​



​Time:
​HALL A
​08:00-10:00

​SCIENTIFIC  SESSION 7
SURGICAL TREATMENT
Moderators: Jesús Lafuente, Spain and  Pedro Pablo Alcazar, Spian
​08:00-08:15
​A comprehensive analysis of the STICH trials:  identifying those patients who would benefit from craniotomy 
Alexander David Mendelow, Newcastle University, United Kingdom
​08:15-08:22
O-080 New meta-analysis of Surgery for ICH
Alexander David Mendelow, Newcastle University, United Kingdom
​08:22-08:29
O-081 Brain tissue donation after ICH-Maximising the potential
Christine Elizabeth Lerpiniere, Edinburgh University, United Kingdom
​08:29-08:44
​The CLEAR Trial:  Current Status of Research
Daniel Hanley, Johns Hopkins University, USA
​08:44-08:51
O-082 Navigated endoscopy-assisted ICH evacuation with the Apollo® device and intraoperative CT or robotic cone-beam CT imaging
Nils Hecht, Universitätsmedizin Berlin, Germany
​08:51-08:58
O-083 Prognostic significance of ultraearly hematoma growth in spontaneous intracerebral hemorrhage patients receiving hematoma evacuation
Zhiyuan Yu, West China Hospital, Sichuan University, China
​08:58-09:13
Current Status of the endoscopic hematoma evacuation and surgical innovations for the intracerebral hemorrhage
Takuji Yamamoto, Juntendo University Shizuoka Hospital Japan
​09:13-09:20
O-084 Initial Experiences on Minimally Invasive Trans-Sulcal Endoscopic Surgery of Spontaneous Basal Ganglia Intracerebral Hemorrhage
Juan Manuel L Mariano, St. Luke's Medical Center, Philippines
​09:20-09:27
O-085 Application of Two Novel Techniques of Minimally Invasive Image Guided Inter-Fascicular Evacuation (MIS) of Spontaneous Basal Ganglia Hemorrhages (SC-ICH)
Jean Louis Caron, UT Health San Antonio, USA
​09:27-09:42
​The MISTIE Trial:  Current Status of Research
Mario Zuccarello, Mayfield Brain and Spine Clinic, USA
​09:42-09:49
O-086 Microsurgical versus Endovascular Treatments for Blood-Blister Aneurysms of the Internal Carotid Artery: A Retrospective Study of 83 Patients in a Single Center
Yanming Ren,  West China Hospital, Sichuan University, China
​09:49-09:56
O-087 Midline shift distance and early mortality in MISTIE 3 patients
Yunke Li, Johns Hopkins University, USA
​10:15-10:45
COFFEE BREAK
10:45-13:30
SCIENTIFIC  SESSION 8
RANDOMISED CONTROL TRIALS 
Moderators: Alexander David Mendelow, UK and David Rodríguez-Rubio, Spain
​10:45-11:00
​STICH 3:  Improving craniotomies 
Chao You, West China Hospital, Sichuan University, China
11:00-11:07
O-088 Screen failure rates in MISTIE III
Radhika Avadhani, Johns Hopkins University, USA
​11:07-11:14
O-089 Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of acute Cerebral Hemorrhage (ATACH)-2 Trial
Adnan Qureshi, University of Missouri, USA
​11:14-11:29
​RCTs for traumatic ICH
Peter Hutchinson, University of Cambridge, United Kingdom SYKPE PRESENTATION
​11:29-11:36
O-091 The Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT): safety and tolerability of the “Triple Pill” after 2 week active run-in
Ruth Freed, The George Institute for Global Health, Australia
​11:36-11:43
O-092 Survey Results from the MISTIE III Mobile Application’s Use
Lindsay M Eyzaguirre, Johns Hopkins University, USA
11:43-11:58​
​Meta-analysis of surgical trials for spontaneous ICH
Barbara Gregson, Newcastle University, United Kingdom
​11:58-12:05
O-094 NTERACT3 update: feasibility of an implementation cluster clinical trial
Chao You, West China Hospital, Sichuan University, China
​12:05-12:12
O-095 Identification and Application of Radiographic Characterization of Spontaneous ICH-Mediated Encephalomacia (IME) in the MISTIE-III Cohort
Ayushi Gautam, Johns Hopkins School of Medicine, USA
​12:12-12:27
​Designing RCTs for ICH in the new century: The good, the bad and the ugly
Daniel Hanley, Johns Hopkins University, USA
​12:30-12:45
​Closing Remarks & Highlights
Presented by Magdy Selim, USA
12-45-13:00
​Closing



Time:​
​HALL B
​​08:00-10:00
Short Oral Presentations Session​
Moderators: Daniel Hanley, USA and David Rodriguez,-Rubio Spain
08:00-08:03
SO-001 Study update: INTERACT3 - a stepped-wedge cluster randomized trial
Guojuan Cheng, The George Institute for Global Health (Australia) Beijing Representative Office, China​
​08:03-08:06
SO-002 Neurosurgical intervention for supratentorial spontaneous intracerebral haemorrhage: A systematic review and meta-analysis of randomised controlled trials
Lotte Sondag, Radboud University Medical Center, The Netherlands
08:06-08:09
SO-003 Initial experience with minimally invasive parafascicular surgical approach for evacuation of supratentorial intracerebral hemorrhage
Nicolas Kon Kam King, National Neuroscience Institute, Singapore
08:09-08:12
SO-004 Neuroendoscopic Evacuation of Intraventricular Hemorrhage in the Preterm Newborns Using Ventriculoport
Hakan Simsek, Sultan Abdulhamid Han Teaching Hospital, Turkey
08:12-08:15​
SO-005 Stereotactic Aspiration with Thrombolysis for Spontaneous Intracerebral Hemorrhage: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
Christina M. Grabarits, Johns Hopkins University School of Medicine, USA
​08:15-08:18
SO-006 Diabetes mellitus and the risk of aneurysmal subarachnoid haemorrhage: A systematic review and meta-analysis of current evidence
Xiyang Yao, The First Affiliated Hospital of Soochow University, China
​08:18-08:21
SO-007 Evaluating outcomes from brainstem evacuation: An algorithm for selection and timing of intervention in patients with hypertensive brainstem haemorrhages
Swati Jain, National University Health System, Singapore
08:21-08:24
SO-008 Risk Factors for Early Hemorrhagic Progression after Traumatic Brain Injury: A Focus on Lipid Profile
Kwangwook Jo, The Catholic University of Korea, South Korea
​08:24-08:27
SO-009 Regimented start-up programs lead to faster site activation
Karen Lane, Johns Hopkins University, USA
​08:27-08:30
SO-010 Systematic Review of Reliability of Perihaematomal Oedema Volume Segmentation and in Patients with Spontaneous Intracerebral Haemorrhage
Nikola Sprigg, University of Nottingham, United Kingdom
08:30-08:33
SO-011 Single IRB review timelines slower than standard IRB processes for site start-up, but improved for changes in research
Karen Lane, Johns Hopkins Medical Institutions, USA
​08:33-08:36
SO-012 Limitation of therapeutic effort in acute intracerebral hemorrhage: Do we apply it correctly?
Tomàs Xuclà Ferrarons, Hospital de la Santa Creu I Sant Pau, Spain
​08:36-08:39
SO-013 Prognosis determinants of severe traumatic brain injury. A hospital based study in one sub saharan african country
Bello Figuim, Central Hospital, Cameroon
08:39-08:42
SO-014 Evaluation of functional situation of patients who had undergone surgery for intraventricular hemorraghe after 5 years of their admission into ICU
Maria Del Carmen Molina De La Torre, Hospital Universitario de Jaén, Spain
​08:42-08:45
SO-015 An elderly lady with multiloculated bilateral subdural hematomas
Bella Richard, United Kingdom
08:45-08:48
SO-016 The application of Willis covered stent in the treatment of Blood Blister aneurysms: a single center experience and systematic literature review
Lun Xin Liu, West China Hospital of Sichuan University, China
08:48-08:51​
SO-017 Association between good modified Rankin Scale and cognition impairment status among hemorrhage stroke survivor patients: Results from CLEAR III and MISTIE III trials
Radhika Avadhani, Johns Hopkins University, USA
​08:51-08:54
SO-058 Family Presence and Intracerebral Hemorrhage Characteristics: Role in Predicting Length of Stay and Outcomes after Minimally Invasive Evacuation
Natalia Romano Spica, Icahn School of Medicine at Mount Sinai, USA
​08:54-08:57
SO-019 Dual antiplatelet therapy associated with reduced risk of clinical vasospasm in aneurysmal subarachnoid hemorrhage
Dae Won Kim, Wonkwang University Hospital, South Korea
​08:57-09:00
SO-020 The prevalence of dynamic CT angiography “spot sign” and its predictability of clinical outcome in acute intracerebral hemorrhage: a prospective cohort study
Hee Sahng Chung, University of Ottawa, Canada
​09:00-09:03
SO-021 Differential Risk factor profile for intracerebral hemorrhage according to location: A nested case- control analysis in the Framingham Heart Study
Vasileios Arsenios Lioutas, Harvard Medical School, USA; Boston University School of Medicine, USA
​09:03-09:06
SO-022 Recovery of Visual Function after Occipital Hemorrhage Evacuation by Minimally Invasive Neurosurgery (MIN)
Susanna Antal, LKHF Neurosurery, Teaching Hospital University, Austria
​09:06-09:09
SO-023 STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage (STATICH)
Kristin Tveitan Larsen, Oslo University Hospital, Norway; Akershus University Hospital, Norway; University of Oslo, Norway
​09:09-09:12
​SO-024 Endovascular management of Hemorrhagic Dural Arteriovenous Fistulas
Jose Angel Larrea, Donostia Universitary Hospital, Spain
​09:12-09:15
SO-025 Endovascular treatment in comparison with surgery for Aneurismatic Subarachnoid Hemorrhage: Analysis of results and costs
Isabel Maria Ortiz, Hospital Universitario Virgen de las Nieves, Spain
​09:15-09:18
SO-026 High In-Hospital Systolic Blood Pressure Variability and Poor Functional Outcome in Primary Intracerebral Hemorrhage Patients
Jennifer R Meeks, McGovern Medical School at UTHealth, USA
​09:18-09:21
​SO-027 Novel clinical trial design: INTERACT4, an ambulance-delivered PROBE trial of intensive BP lowering
Lili Song, The George Institute China, Peking University Health Science Center, China
​09:21-09:24
SO-044 Minimally Invasive Endoscopic Evacuation of Intracerebral Hemorrhage is Safe with the NICO Myriad
Rui Song, Icahn School of Medicine at Mount Sinai, USA
​09:24-09:27
​SO-029 The Impact of Inter-hospital Transfers versus In-Hospital Emergency Department Admissions on Intracerebral Hemorrhage Patients Undergoing Minimally Invasive Evacuation
Julianne Kleitsch, Icahn School of Medicine at Mount Sinai, USA
​09:27-09:30
SO-031 Case report: A patient with hemorrhagic subtype of moyamoya disease
Jana Kenda, UMC, Slovenia
​09:30-09:33
SO-033 Blockage of glymphatic system contribute to enhanced neuroinflammation in intraventricular hemorrhage
Si Zhang, West China Hospital, China 
​09:33-09:36
SO-034 High risk of seizures in infants with ruptured intracranial aneurysms: distal arterial lesions with lobe intracranial hemorrhage
Ruiqi Chen, West China Hospital of Sichuan University, China
​09:36-09:39
SO-035 Predictive Significance of the Black Hole Sign for Hematoma Expansion in Intracerebral Hemorrhage
Rui Tian, West China Hospital, Sichuan University, China
​09:39-09:42
​SO-037 A retrospective audit of 96 patients with spontaneous intracerebral haemorrhage admitted to West Suffolk Hospital, UK,between May 2017 and October 2018 considering the severity and the outcomes and DOAC use vs Warfarin and the outcomes
Dominika Danuta Raciborska, University of Cambridge, United Kingdom
​09:42-09:45
SO-038 The efficacy and mechanisms of adipose-derived stem cells on the treatment of intracerebral hemorrhage
Gaigai Li, Huazhong University of Science and Technology, China
​09:45-09:48
SO-039 Increasing mortality rates of intracerebral hemorrhage associated with direct oral anticoagulants in Japan
Tomohide Adachi, Tokyo Saiseikai Central Hospital, Japan
10:00-12:30
​PARALLEL  SESSION 1
TRAUMATIC INTRACEREBRAL HEMORRHAGE
Moderators: Jesús Lafuente, Spain and Mario Zuccarello, USA
10:00-10:15​
​Risk factors associated with progression of traumatic intracerebral hemorrhage
Alfonso Lagares, Universidad Complutense de Madrid, Spain
10:15-10:22
O-048 Burr-hole drainage for treatment of chronic subdural hematomas: experience with 328 cases
Lun Xin Liu, West China Hospital, Sichuan University, China
​10:22-10:29
O-049 Subdural haematoma management in newborns: a case series
Tomaz Velnar, University Medical Centre Ljubljana, Slovenia
​10:29-10:36
O-050 Identifying complications in traumatic neurosurgical patients of ICU
Arooj Fatima, Sir Gangram Hospital, Pakistan
​10:36-10:51
Decompressive craniectomy for acute subdural hematomas
Antonio Belli, University of Birmingham, United Kingdom
10:51-10:58
O-053 Efficacy and Safety of Four Interventions for Spontaneous Supratentorial Intracerebral Hemorrhage: a Network Meta-Analysis of Randomized Controlled Trials
Chao Pan,  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China 
​10:58-11:05
O-054 Clinical and Radiological Predictors of Cognitive Impairment after Intracerebral Haemorrhage at Day 90 and Day 365 using data from the Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
Andrew Belcher, University of Nottingham, United Kingdom
​11:05-11:12
O-055 Specific Intraventricular Hemorrhage Severity Associated with Subsequent Incontinence and Gait Dysfunction
Tyler P Behymer, University of Cincinnati College of Medicine, USA
​11:12-11:27
​Post-traumatic cognitive impairment: strategies to support function recovery  
Michael Nilsson,  The University of Newcastle, Australia
11:27-11:34
O-056 Clinical Predictors of Health-Related Quality of Life for Patients with Intracerebral Hemorrhage and Intraventricular Hemorrhage
Lourdes Carhuapoma, Johns Hopkins Hospital, USA
​11:34-11:41
O-057 Vitamin D – a new perspective in treatment of cerebral vasospasm
Sepide Kashefiolasl, University Hospital Frankfurt, Germany
​11:41-11:48
​O-058 Unraveling mechanisms of axonal degeneration and endothelial cell damage in intracerebral hemorrhage
Marietta Zille, Fraunhofer Research Institution for Marine Biotechnology and Cell Technology, Germany; University of Luebeck, Germany
​11:48-12:03
​Surgical and Medical Management of Contusions
Marc Maegele, Cologne-Merheim Medical Center - University Witten-Herdecke, Germany
12:03-12:10
O-059 Non-invasive, Image-guided Doppler-ultrasound based Intracranial Pressure Measurement Instrument in the Management of Intracerebral Haemorrhage: Preliminary Report
T Forcht Dagi, Boston Neurosciences, USA
13:30-15:00
​Networking Event - Lunch Reception
15:00-15:55
Oral Presentations Session
Moderators: Ramón Navarro, UAE and Sujoy K Sanyal, India
14:53-15:00
O-108 Stereotactic Intracerebral Hemorrhage Underwater Blood Aspiration (SCUBA) improves mortality after intracerebral hemorrhage
Rui Song, Icahn School of Medicine at Mount Sinai, USA
​15:00-15:07
​O-060 Determining the optimal shape-related indicator on non-contrast computed tomography for predicting hematoma expansion in spontaneous intracerebral hemorrhage
Jun Zheng, West China Hospital, Sichuan University, China
​15:07-15:14
O-061 The Capacity of Blend Sign on Noncontrast Computed Tomography in Predicting Poor Outcome of Patients with Intracerebral Hemorrhage
Fan Xia, West China Hospital, China
​15:14-15:21
​O-062 Regional differences in BP management in INTERACT2
Xia Wang, The George Institute for Global Health, Australia
​15:21-15:28
O-063 Brain Tissue Iron Quantification by MRI at Periphery of Hematoma in Patients with Intracerebral Hemorrhage: Preliminary Translational Evidence in First 10 Patients
Neeraj Chaudhary, Michigan Medicine, USA
​15:28-15:35
O-064 Regional Patterns of Care for Patients with Primary Intracerebral Hemorrhage in the Greater Cincinnati Northern Kentucky Stroke Study
Farhaan Shaheer Vahidy, UTHealth Houston, USA
​15:35-15:42
​O-065 Metabolomics reveals the self-repair associated metabolism in experimental intracerebral hemorrhage
En Hu, Xiangya Hospital, Central South University, China
​15:42-15:49
O-066 Endogenous plasminogen activators are associated with haematoma progression in spontaneous intracerebral haemorrhage: findings from the TICH-2 plasma biomarkers sub-study
Nikola Sprigg, University of Nottingham, United Kingdom
15:49-15:56
​O-101 Sensitivity of non-enhanced computed tomography in identifying the location of a ruptured cerebral aneurysm in patients with aneurysmal subarachnoid hemorrhage
Marcin Sawicki, Pomeranian Medical University in Szczecin, Poland
16:00-18:30
​PARALLEL  SESSION 2
ANEURYSMS, AVMs and CAVERNOUS MALFORMATIONS
Moderators: David Rodríguez-Rubio, Spain and Chao You, China
16:00-16:15​
Endovascular Does Not Always Equal Minimally Invasive: Decision making on Coiling or Clipping for everyday Aneurysms: the perspective of a Dual-trained Neurosurgeon
Sujoy K Sanyal, Rabindranath Tagore Hospital and Armenian Church Trauma Center, India
​16:15-16:22
O-068 Safety and efficiency of flow diverters for treating small intracranial aneurysms: A systematic review and meta-analysis
Xiyang Yao, The First Affiliated Hospital of Soochow University, China
​16:22-16:29
O-069 Entire Orifice Blocking-Assisted Microsurgical Treatment: Clipping of Intracranial Giant Wide-Neck Paraclinoid Aneurysms
Lu Ma, West China Hospital, Sichuan University, China
​16:29-16:36
O-070 Prediction of postoperative stroke after intracranial aneurysm surgery using changes in intraoperative evoked potential monitoring
Jungjae Lee, The Catholic University of Korea, South Korea
​16:36-16:51
​Timing for treatment in ruptured AVMs:  the  neuroradiologist point of view
Pedro Pablo Alcázar,  Hospital Universitario Virgen de las Nieves, Spain
16:51-16:58
O-071 Emergent microsurgical treatment of arteriovenous malformation-related intracranial hemorrhage
Qiao Zhang, West China Hospital, Sichuan University, China
​16:58-17:05
O-073 In-hospital Delirium and Long-Term Cognitive Outcomes among Patients with Intracerebral Hemorrhage and Subarachnoid Hemorrhage: A population-based cohort analysis
Jennifer R Meeks, McGovern Medical School at UTHealth, USA
​17:05-17:12
O-074 Scale up of the ‘ABC’ care bundle for acute intracerebral haemorrhage in a UK urban region: 1-year post-launch quantitative evaluation and development of an app to support acute stroke teams
Emily Birleson, Salford Royal Foundation Trust, United Kingdom
​17:12-17:27
Surgical management strategy for complex AVMS
Francisco González-Llanos,  Hospital Virgen de la Salud, Spain
​17:27-17:34
O-075 Deep Learning for Automated Segmentation of Hematoma and Perihematomal Edema Volumes in Supratentorial Intracerebral Hemorrhage
Rajat Dhar, Washington University School of Medicine, USA
​17:34-17:41
O-076 Andexanet alfa for Treatment of Factor Xa inhibitor-related Acute Major Bleeding
Truman John Milling Jr., Seton Dell Medical School Stroke Institute, USA
​17:41-17:48
O-077 Gamma Knife Radiosurgery for Brainstem Cavernous Malformations
Jing Chen, West China hospital, Sichuan University, China
​17:48-18:03
​Endovascular strategy in AVM
Ramón Navarro, Clevelan Clinic, Abu Dhabi, UAE
18:03-18:18​
​Cavernous malformations of the brain stem
Miguel Ángel Arráez, Carlos Haya University Hospital, Spain
18:18-18:25
O-078 The association between long-term oral antithrombotic drug use and intracerebral haemorrhage for patients with cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis
Susanna M Zuurbier, Amsterdam University Medical Centers, The Netherlands
​18:25-18:32
O-079 Confirmation of the Utility of Modeling Intracerebral Hemorrhage Outcomes to Predict Effectiveness of Treatment: Update with Phase 3 Results
Thomas A Kent, Texas A&M Health Science Center, USA
​18:40-19:50
​Industry Sponsored Symposium


Time:​
​HALL B
​08:00-10:00
Short Oral Presentations Session
Moderators: David Rodriguez, Spain and Bello Figuim, Cameroon
​08:00-08:03
SO-041 Radiologic features of intracerebral hemorrhage as predictors of intrahospital mortality and functional outcome at discharge
Ane Ugarte Nuño, Hospital Universitario Donostia, Spain
​08:03-08:06
SO-042 Altered Expression Profiles of Transfer-RNA-Derived Small RNAs in an Experimental Intracerebral Hemorrhage
Pengfei Li,  Xiangya Hospital, Central South University, China
​08:06-08:09
SO-043 A survey of usual care of physiological variables in ICH Patients - INTERACT3 Trial
Lili Song, The George Institute China, Peking University Health Science Center, China
​08:09-08:12
SO-045 Establishing Criteria for Triage of Primary Intracerebral Hemorrhage Patients to Higher Level of Care
Jennifer R Meeks, McGovern Medical School at UTHealth, USA
​08:12-08:15
SO-046 A Case of Subdural Hematoma After Epidural Blood Patch in a Spontaneous Intracranial Hypotensive Patient With Multi-Level Cerebrospinal Fluid Leakage
Young Joo, Department of Anesthesiology and Pain Medicine, South Korea
​08:15-08:18

​08:18-08:21
SO-057 Predictors of early in-hospital mortality in patients with spontaneous intracerebral hemorrhage
David Campo Caballero, Donostia University Hospital, Spain
​08:21-08:24
SO-049 Initial Experiences on Early Surgery for Spontaneous Basal Ganglia Intracerebral Hemorrhage
Giannina Krishna Chua Go, St. Luke's Medical Center Global City, Philippines
​08:24-08:27
SO-050 Neuromonitoring Further Role for ICH Management - A Pilot Study
Ana V. Ferreira, Centro Hospitalar Universitário de São João, Portugal
​08:27-08:30
SO-051 Admitting Patients with Small Intracerebral Hemorrhage and Minor Deficits to a Neurologic Step-Down Unit rather than Intensive Care Unit is Safe and Results in Shorter Total Length of Stay
Flavia Lee, Washington University School of Medicine, USA
​08:30-08:33
SO-052 Predictive accuracy of neutrophil to lymphocyte ratio on long-term outcome in patients with spontaneous intracerebral hemorrhage
Fan Zhang, West China Hospital, China
​08:33-08:36
SO-053 Clinical characteristics and outcomes of intracerebral hemorrhage with coagulation abnormalities
Wei Chen, West China Hospital of Sichuan University, China
​08:36-08:39
SO-054 Island sign predicts long-term poor outcome and mortality in patients with intracerebral hemorrhage
Hao Li, West China Hospital, China
​08:39-08:42
SO-055 Red Cell Distribution Width Predicts Incident Stroke: A Dose-response Meta-analysis
Lu Wang, Sichuan University, China
​08:42-08:45
SO-056 The Role of Ultrasound in ICH Evacuation
Klaus D M Resch, Teaching hospital University, Austria
​08:45-08:48

​08:48-08:51
SO-060 Intracranial hemorrhage: clinical significance of shape
Kornelia M Kliś, Jagiellonian University Medical College, Poland
​08:51-08:54
SO-061 Association of Various Perihematomal Edema Metrics to Primary Intracerebral Hemorrhage Clinical Outcomes
Patrick Matic Yalung, St. Luke's Medical Center, Philiipines
​08:54-08:57
SO-062 Spontaneous intracranial hemorrhage associated with novel oral anticoagulants
Han Lin Yen, Tainan Municipal Hospital, Taiwan
​08:57-09:00
SO-064 Radiologic characteristics and high risk of seizures in infants with ruptured intracranial aneurysms: case report and review of the literature
Yi Liu, West China Hospital, Sichuan University, China
​09:00-09:03
SO-065 Hemicraniectomy with minimally invasive evacuation for intracranial hematoma: a novel hybrid technique
Leonard H Verhey, Michigan State University, USA
​09:03-09:06
SO-066 Evacuation of Traumatic Intracranial Haemorrhage by MIN Techniques
Klaus D M Resch, Teaching Hospital University, Austria
​09:06-09:09
SO-067 The risk of Hemorrhagic Transformation after intravenous thrombolysis in cardioembolic Ischemic stroke
Lina Carazo Barrios, Hospital Clínico Universitario Virgen de la Victoria, Spain
​09:09-09:12
SO-068 MRI findings of primary hypertensive intracerebral hemorrhage at chronic stage
A Hyun Cho, Catholic University of Korea, South Korea
​09:12-09:15
SO-069 Intracerebral haematoma evacuation with minimally invasive technique: a case study
Tomaz Velnar, Universy medical Centre Ljubljana, Slovenia
​09:15-09:18
SO-070 Approach of General Surgeons towards patients presented with traumatic brain injury. A critical analysis on the use of Computed Tomography Head in Emergency department
Arooj Fatima, Sir Gangaram Hospital, Pakistan
​09:18-09:21
SO-071 Register-based research of intracerebral haemorrhage in Denmark: Possibilities and challenges
Stine Munk Hald, , University of Southern Denmark; Odense University Hospital, Denmark
​09:21-09:24
SO-072 The effectiveness of cognitive training in schizophrenia like disorder after hemorrhagic stroke
Simona Trifu, University of Medicine and Pharmacy "Carol Davila", Romania
​09:24-09:27
SO-073 How Do We Organize a Clinical Trial?
Xi Li, West China Hospital, Sichuan University, China
​09:27-09:30
SO-074 A New Risk Factor for lung infection in spontaneous intracerebral heamorrhage patients
Xiaoyu Wang, West China Hospital, Sichuan University, China
​09:30-09:33
SO-075 Transcriptome-wide N6-methyladenosine methylome profiling of rat cortex reveals a novel mechanism for Xuefu Zhuyu decoction in experimental traumatic brain injury
Tao Tang, Xiangya Hospital, Central South University, China
​09:33-09:36
SO-076 Hemorrhagic strokes in Guinea compared to Belgium
Charlotte Damien, Université Libre de Bruxelles, Hopital Erasme, Belgium
​09:36-09:39
SO-077 Safety indicators in patients with subarachnoid hemorrhage and its relationship with results of medical attention
Pamela Rodriguez Salgado, ABC Medical Center, Campus Observatorio, Mexico
​09:39-09:42
SO-078 Immediate reversal of anticoagulation effect of dabigatran in hemorraghic stroke
Krisztian Pozsegovits, Dr. Kenessey Albert Hospital, Balassagyarmat, Hungary
​09:42-09:45
SO-079 Primary intracerebral haematoma evacuation through external ventricular drainage
Tomaz Velnar, University Medical Centre Ljubljana, Slovenia
​09:45-09:48
SO-080 Genetic polymorphism of apolipoprotein E in hemorrhagic stroke: study case-control
Sabrina Boumendjel, Faculty of Sciences, Department of Biochemistry, Annaba-Algeria
​09:48-09:51
SO-081 Arteriovenous malformations (AVMs) and haemorrhagic stroke-Case presentation
Marius Gheorghitescu, Boston Hospital, United Lincolnshire Health Trust,United Kingdom
​09:51-09:54
SO-082 Neurological Impact of Renal Stenosis
Lina Carazo Barrios,  Hospital Clínico Universitario Virgen de la Victoria, Spain
​09:54-09:57
SO-083 Intracerebral hemhorrage in very elderly pacients: medical and ethical aspects
Baltateanu Doru, S.U.U. Elias, Romania
​09:57-10:00

​10:00-10:03
SO-085 Epidemiology and risk factor profile of Primary intracerebral hemorrhage in sea coast population of South India- an observational study
Sangamithra Gandra, Narayana Medical College and Hospital, India
10:15-13:00
​PARALLEL  SESSION 3
INTRACEREBRAL HEMORRHAGE IN THE NON-INTRAPARENQUIMATOUS SPACES:  SAH, SDH and IVH
Moderators:  Jesus Lafuente, Spain and Alfonso Lagares, Spain
​10:15-10:30
​Safety and efficacy of thrombolysis in intraventricular hemorrhage
Daniel Hanley, Johns Hopkins University, USA
10:30-10:37
O-096 Endoscopic Evacuation of Thalamic Hemorrhage with Intraventricular Extension
Erickson Fernando Torio, St. Luke's Medical Center, Philippines
​10:37-10:44
O-097 The clinical characteristics and burden after hemorrhagic stroke in patients with cerebral venous sinus thrombosis
Wei Chen, West China Hospital of Sichuan University, China
​10:44-10:51
O-098 Delayed Calculation of Multiple Intracerebral Hemorrhage Scores Outperform Baseline Scoring in Acute Intracerebral Hemorrhage
Ronda Lun, University of Ottawa, Canada
​10:51-10:58
O-100 Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Parenchymal Hematoma Growth and Prognosis
Qi Li,  The First Affiliated Hospital of Chongqing Medical University, China
​10:58-11:05
O-103 A practical 3D-printed model for training of endoscopic and exoscopic intracerebral hematoma surgery with a tubular retractor
Junhao Zhu, Jinling Hospital, School of Medicine, Nanjing University, China
​11:05-11:20
New therapeutic targets in early neurological deterioration after SAH
John Zhang, Loma Linda University School of Medicine, USA
11:20-11:27
O-104 Intracerebral hemorrhage with tentorial herniation: conventional open surgery or emergency stereotactic craniopuncture aspiration surgery?
Guofeng Wu, Affiliated Hospital of Guizhou Medical University, China
​11:27-11:34
​O-105 Diffusion Tensor Imaging of the Cortical Spinal Tract in Minimally Invasive Surgical Endoscopic Evacuation of Intracerebral Hemorrhage
Christopher P Kellner, Icahn School of Medicine at Mount Sinai, USA
​11:34-11:41
O-106 Targeting Spot Sign in Intracerebral Hemorrhage with NICO BrainPath Minimally Invasive Parafascicular Surgery to Prevent Hematoma Expansion
Mark D Bain, Cerebrovascular Center, Cleveland Clinic, USA
11:41-11:56
Technical challenges in surgical treatment of ruptured aneurysms presenting as intracerebral hematoma
Ángel Horcajadas, Hospital Universitario Virgen de las Nieves, Spain
​11:56-12:11
​Dissecting  sulci to access ICH: Minimally invasive surgery, the EnrICH Trial and BrainPath device
Gustavo Pradilla, Emory University, USA
​12:11-12:18
O-107 Novel Technique of Minimally Invasive Image Guided Catheter Inter-Fascicular Evacuation of Spontaneous Basal Ganglia Hemorrhages Results in Successful Hemorrhage Evacuation and Improved Short-term Outcomes
Jean Louis Caron, UT Health San Antonio, USA
​12:18-12:25
O-109 Minimally invasive parafascicular surgery for supratentorial intracerebral hemorrhage
Nicolas Kon Kam King,  National Neuroscience Institute, Singapore


Keep Me Updated